New Home2026-05-21T14:39:16+10:00

Transform Your Response

Transform Your Response

Patient-Led. Built From Lived Experience.

Learn to keep options open.

Keep options open

Where Patients Lose

The Patient Survival System

Biliary 101

Why This Foundation Exists

I am a late-stage 4 cholangiocarcinoma survivor and co-founder of Cholangiocarcinoma Foundation Australia alongside my wife, Claire.

What most patients need in that moment is not reassurance alone.

They need orientation.
What matters now.
What comes next.

That is why this Foundation exists.

Everything we build is designed around one goal:

Improving today’s patient survival – today.

View my bio

Just yesterday, I was a person. Today, I am a patient.
I must become the best patient I can be, so that I can become that person again.

Steve

Our People Our Community Our Culture

108, 2019

Cholangiocarcinoma and FGFR2

By |

FGF and FGFR2 is a signalling pathway - Fibroblast growth factor signalling uses a fibroblast growth factor receptor (FGFR2) ligand during cell cycle and cell division. The ligand embeds itself into the cell membrane to recieve and deliver growth factors into the cell.

Testimonials

Go to Top